-
Corynoline Induces Apoptosis in Osteosarcoma via Src/JNK Pat
2026-05-22
This study elucidates how Corynoline, a natural alkaloid, suppresses osteosarcoma cell growth by inducing G2/M cell cycle arrest and promoting mitochondrial apoptosis through Src/JNK pathway activation. The findings reveal new mechanistic insights for targeted osteosarcoma therapy and inform the design of apoptosis-focused cell death assays.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio
2026-05-21
This study demonstrates that specific angiotensin peptides, including short C- and N-terminal fragments, significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor. These findings reveal a novel link between renin-angiotensin system peptides and viral entry mechanisms, with important implications for both cardiovascular and infectious disease research.
-
Phosphoproteomic Remodeling in RCC Under Chronic Cabozantini
2026-05-21
This study reveals how acute versus chronic Cabozantinib (XL184) exposure leads to distinct, timescale-dependent phosphoproteomic remodeling in renal cell carcinoma (RCC) cells. The findings provide systems-level evidence that chronic treatment sustains MET inhibition but selectively reprograms adhesion- and motility-associated signaling, informing future mechanistic and translational RCC research.
-
MitMAB in Organoid Models: Redefining Endocytosis Research
2026-05-20
This thought-leadership article explores how MitMAB, a potent dynamin GTPase inhibitor, is catalyzing new advances in endocytosis and membrane trafficking studies within intestinal stem cell (ISC) organoid models. Blending mechanistic insight, protocol guidance, and strategic vision, it addresses key challenges facing translational researchers and positions APExBIO’s MitMAB as a cornerstone of next-generation experimental design.
-
Caveolin-1 Regulates Cholesterol Homeostasis in MASLD Progre
2026-05-20
This study demonstrates that Caveolin-1 (CAV1) protects against the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) by restoring cholesterol balance, thereby reducing endoplasmic reticulum (ER) stress and pyroptosis in hepatocytes. These findings clarify a mechanistic link between cholesterol homeostasis and hepatic inflammation, underscoring CAV1’s central regulatory role and suggesting new avenues for research on liver disease pathogenesis and intervention.
-
L-NAME Hydrochloride: Benchmark NOS Inhibitor for Vascular R
2026-05-19
L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) is a well-characterized, competitive nitric oxide synthase (NOS) inhibitor used extensively in vascular tone regulation and hypertension research. Its potency, water solubility, and validated in vivo effects make it a gold-standard tool for dissecting NO-dependent signaling in cardiovascular and inflammation studies.
-
Re-evaluating ACE and Aminopeptidase Inhibitors in Peptidase
2026-05-19
This study systematically compares the selectivity and potency of widely used metallopeptidase inhibitors—particularly ACE inhibitors and bestatin—against key mammalian aminopeptidases. The findings clarify the specificity profiles of these inhibitors, which has significant implications for research targeting hypertension, heart failure, and peptide metabolism.
-
LDH Cytotoxicity Assay Kit: Robust Cell Cytotoxicity Measure
2026-05-18
The LDH Cytotoxicity Assay Kit from APExBIO empowers researchers to accurately quantify cell damage and apoptosis in advanced biomedical workflows. Its non-radioactive, colorimetric design ensures high sensitivity, reproducibility, and safety—ideal for applications ranging from cancer research to nanomaterial biocompatibility testing.
-
2-(4,5,6,7-tetrabromo...) Acetic Acid: A Versatile Small Mol
2026-05-18
The CK2 and ERK8 inhibitor (2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid) empowers translational researchers to dissect protein phosphorylation and phase separation mechanisms with quantitative precision. Its dual kinase inhibition capacity and distinct physicochemical properties make it an advanced molecular tool for enzyme interaction and condensate biology studies.
-
Fusobacterium nucleatum EVs Enhance Colorectal Cancer Coloni
2026-05-17
This study demonstrates that extracellular vesicles (EVs) from Fusobacterium nucleatum are enriched in colorectal cancer (CRC) tissues and facilitate bacterial adhesion and colonization. These findings reveal a new mechanism by which F. nucleatum EVs prime the tumor microenvironment, offering insights for targeting microbial-tumor interactions in CRC.
-
DiscoveryProbe Protease Inhibitor Library: Applied Screening
2026-05-16
The DiscoveryProbe™ Protease Inhibitor Library empowers researchers to investigate protease inhibition across diverse biological systems, streamlining high-throughput screening and mechanistic studies in apoptosis, cancer, and infectious disease research. Its automation-ready, quality-controlled design ensures reproducibility and depth, setting it apart for both routine and advanced assay development.
-
TGF-β Orchestrates Sca-1 Expression in Mammary Stem Cells
2026-05-15
This study elucidates how TGF-β signaling dynamically regulates Sca-1, a key stem cell marker, and drives plasticity in pre-neoplastic mammary epithelial cells. The findings clarify the mechanistic links between TGF-β, stem-cell lineage commitment, and tumor-initiating cell emergence, offering new targets for epithelial and cancer biology research.
-
Dextrose (D-glucose): Powering Precision in Glucose Metaboli
2026-05-15
Dextrose (D-glucose) from APExBIO is a cornerstone reagent for advancing glucose metabolism and immunometabolic research, especially in hypoxic tumor microenvironments. This article decodes its optimal application, troubleshooting, and comparative advantages, equipping labs to achieve reproducible, high-impact results.
-
Fingolimod (FTY720) in Cell Assays: Best Practices & Data Re
2026-05-14
This article delivers scenario-driven guidance for using Fingolimod (FTY720) (SKU A8548) in cell viability, proliferation, and cytotoxicity assays, emphasizing reproducibility, compatibility, and workflow optimization. Researchers will find evidence-backed recommendations, numeric assay parameters, and candid vendor selection advice—all grounded in recent literature and APExBIO’s product specifications.
-
ICG001 in Wnt/β-Catenin Pathway Inhibition: Mechanistic Insi
2026-05-14
Discover how ICG001, a selective Wnt/β-catenin pathway inhibitor, enables advanced mechanistic and translational research in EMT-driven fibrosis and cancer. This article provides a deeper scientific analysis of ICG001’s mode of action and its strategic utility in dissecting CBP/β-catenin interactions for disease modeling.